TY  - GEN
AU  - Bolenz,C
AU  - Trojan,L
AU  - Honeck,P
AU  - Schöppler,G
AU  - Herrmann,E
AU  - Alken,P
AU  - Michel,M S
AU  - Häcker,A
TI  - [Medical treatment of metastatic renal cell carcinoma after the approval and market entry of multitargeted tyrosine kinase inhibitors in Germany]
SN  - 1438-8820
PY  - 2009///0611
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - Benzenesulfonates
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Clinical Trials, Phase III as Topic
KW  - Cohort Studies
KW  - Data Interpretation, Statistical
KW  - Female
KW  - Germany
KW  - Humans
KW  - Indoles
KW  - Kidney Neoplasms
KW  - Male
KW  - Medical Oncology
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Protein-Tyrosine Kinases
KW  - antagonists & inhibitors
KW  - Pyridines
KW  - Pyrroles
KW  - Sorafenib
KW  - Sunitinib
KW  - Surveys and Questionnaires
KW  - Time Factors
KW  - Urology
N1  - Publication Type: Comparative Study; Evaluation Study; Journal Article
UR  - https://doi.org/10.1055/s-2008-1038176
ER  -